Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

RGCNasdaqHealthcareDrug Manufacturers - Specialty & Generic
$24.11 +0.40 (+1.69%)

Company Overview

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Price Chart

Historical Trend (Absolute Values)
RGC Price
05/1205/2005/28

Financial Metrics

Market Capitalization$9.88B
P/E Ratio
Earnings Per Share (EPS)-$0
Dividend Yield
Beta (Volatility)
Price to Book (P/B)12055
52-Week Range$9.39 - $83.60

LAST SCRARED: May 29, 2026

Compare RGC

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.